On August 18th, the Hunan Provincial Department of Industry and Information Technology released the "Announcement on the Proposed Support Projects for Provincial Special Financial Funds of the Provincial Department of Industry and Information Technology in 2022". The company's "R&D and Industrialization Project of 100 Traditional Chinese Medicine Formula Granules" was included in the proposed support projects for provincial special financial funds of the Provincial Department of Industry and Information Technology in 2022. In February 2021, four national ministries and commissions jointly issued the "Announcement on Ending the Pilot Work of Traditional Chinese Medicine Formula Granules". The company's traditional Chinese medicine ultra-fine formula granules were transformed into traditional Chinese medicine formula granules. The future standard research is expected to invest 100 million yuan, and the varieties will increase from 244 to around 600. As of August 18th, the company has submitted filing applications for traditional Chinese medicine formula granules in 24 provincial regions. The company's new production line for traditional Chinese medicine formula granules, which has invested nearly 300 million yuan, has entered the production verification stage. Currently, the progress is smooth, and the production capacity bottleneck that has been plaguing the company's development is expected to be completely resolved. The company's development will enter a fast lane.